---
title: "FLOYD DAVID M — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2bab7045-b173-5531-b2a3-503a18a3ee4e
json: https://whiteintel.dev/api/public/dossier/2bab7045-b173-5531-b2a3-503a18a3ee4e
identifier: sec:0001316536
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FLOYD DAVID M

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001316536`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/2bab7045-b173-5531-b2a3-503a18a3ee4e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2bab7045-b173-5531-b2a3-503a18a3ee4e  

## Ownership & control

### Holdings / subsidiaries

- **PHARMACOPEIA DRUG DISCOVERY INC** (officer) — https://whiteintel.dev/entity/02858e73-ac25-57f0-b020-6191e901991a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FLOYD DAVID M**. Human view: https://whiteintel.dev/entity/2bab7045-b173-5531-b2a3-503a18a3ee4e · Structured JSON: https://whiteintel.dev/api/public/dossier/2bab7045-b173-5531-b2a3-503a18a3ee4e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._